Insight into New Alzheimer's Treatment and COVID-19

This week's MedEvidence Monday Minute conversation takes an exciting turn as Kevin Geddings and Dr. Michael Koren discuss the realm of Alzheimer's disease, exploring a promising new FDA-approved drug and the hope it carries for affected patients. Dr. Koren gave us insight into how this drug may decelerate the progression of Alzheimer's symptoms and its impact on brain plaques. Shifting our attention to the alarming rise of COVID-19 cases in Florida, Dr. Koren issues a warning about the potential of the virus becoming endemic. Still, he also provides a glimmer of hope, introducing us to the possibility of antibody treatments for those ineligible for vaccination. Tune in for an enlightening conversation that navigates through medical breakthroughs and the challenging realities of the healthcare landscape.

Be a part of advancing science by participating in clinical research

Music: Storyblocks - Corporate Inspired

Recording Date: July 10, 2023